Navigation Links
21st Century Oncology Renews Research Commitment with Massachusetts General Hospital
Date:8/20/2013

Fort Myers, FL and Scottsdale, AZ (PRWEB) August 20, 2013

21st Century Oncology today announced it will more closely combine cancer research initiatives with Massachusetts General Hospital (MGH), the original and largest teaching affiliate of Harvard Medical School (HMS).

Currently, 21st Century Oncology, the largest U.S. radiation therapy provider, conducts cancer research alongside MGH within the framework of the Radiation Therapy Oncology Group (RTOG), a national cancer research organization funded by the National Cancer Institute (NCI) to increase the survival rates and improve the quality of life of patients diagnosed with cancer.

In February 2014, the NCI will implement a reorganized cooperative structure, combining three specialized oncology research bodies into one, all-encompassing clinical research collective. The National Surgical Adjuvant Breast and Bowel Project (NSABP), the RTOG, and the Gynecologic Oncology Group (GOG) will become NRG Oncology.

“We are pleased to continue this relationship with Massachusetts General Hospital under the NRG reorganization,” says Daniel Dosoretz, MD, FACR, FACRO, President, CEO and Co-Founder of 21st Century Oncology. “The research and clinical trials we conduct today will improve outcomes for patients with cancer moving forward.”

21st Century Oncology is conducting clinical research trials at sites across the country and assessing the effectiveness of various cancer treatments. “Physicians are currently evaluating advanced therapy in breast cancer, prostate cancer and bladder cancer and look forward to expanding to other sites including lung cancer,” says Steven Finkelstein, MD, National Director, 21st Century Oncology Translational Research Consortium.

“I am pleased as the Principal Investigator of the MGH/HMS, full membership within the RTOG, to be continuing our relationship with 21st Century Oncology to increase the participation for patients on clinical trials as we transition to NRG Oncology in 2014,” says William U. Shipley, MD, FACR, FASTRO who is the Andres Soriano Professor of Radiation Oncology at Harvard Medical School and the MGH. “It is this kind of collaboration and cooperation among leading researchers that will help advance cancer treatment for our patients and save more lives.”

About 21st Century Oncology:
21st Century Oncology is the foremost provider of cancer care services across multiple modalities, and the largest radiation oncology provider. For more than 30 years, 21st Century Oncology has been committed to providing state-of-the-art, academic level treatment options in a patient-centric setting focused on continuous innovation. Headquartered in Fort Myers, Florida, the physician-led company operates in 15 states and 7 countries, with an extensive network of over 300 locations, including approximately 131 radiation therapy facilities. 21st Century Oncology employs or is affiliated with hundreds of physicians in a broad spectrum of cancer-related specialists—working together to deliver the most advanced integrated cancer care. For more information about research and clinical trials with 21st Century Oncology, visit http://www.21stCenturyOncology.com/Research-Outcomes.

About Massachusetts General Hospital
Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The MGH conducts the largest hospital-based research program in the United States, with an annual research budget of more than $775 million and major research centers in AIDS, cardiovascular research, cancer, computational and integrative biology, cutaneous biology, human genetics, medical imaging, neurodegenerative disorders, regenerative medicine, reproductive biology, systems biology, transplantation biology and photomedicine. For more information about Massachusetts General Hospital, visit http://www.MassGeneral.org.

About NRG Oncology
NRG Oncology is a nonprofit research organization formed to conduct oncologic clinical research and to broadly disseminate study results for informing clinical decision-making and healthcare policy. It brings together the National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group (GOG)—each recognized internationally as a research leader.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11039720.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Grace Century, FZ LLC Announces The Quantum Group’s Submission for EMR Platform MU1 Certification
2. Net Worth TV to Air Software Innovations for the 21st Century
3. Narconon Gabbiano Celebrates a Quarter Century of Saving Lives in Lecce, Italy
4. RKNet Studios Announced Cognitions Bridge Games to Help Students Develop Cognitive Abilities to Support Learning in the 21st Century Education
5. Grace Century’s #EHR Project with Quantum Group Sees Final U.S. Health and Human Services Ruling as Potential Boon to Patent Portfolio and Revolutionary Platform PWeR2.0
6. Creighton Professor Explores Bioethics For The 21st Century In Updated Book
7. New Century Coal Signs Option Adding Over 5 Million Tons; Set to Become Industry Reserve Leaders
8. Study finds newspapers have changed coverage of ice hockey concussions over last quarter-century
9. International Conference on Governance of Tobacco in the 21st Century
10. JNL Fusion Coined "Workout of the Century" by Top Acupuncturist, Healer & Holistic Expert Janine Jozwiak, Who Owns and Runs Highly Sought After Wellness Clinic
11. Citizen science more than a century later: Ordinary people go online to track Gulf oil spill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... ... Southland Log Homes , designer and manufacturer of America’s Favorite Log ... be found on its website at SouthlandLogHomes.com. , The designs of the wood ... craftsmanship of timber post and beam construction. The result is a barn that ...
(Date:5/27/2016)... , ... May 27, 2016 , ... W.S. Badger ... announced today that it has been recognized as one of the best small businesses ... was named as one of nine small businesses providing progressive benefits to new parents ...
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... With over ... to walk, the demand for a sustainable product to aid in the rehabilitation process ... aid in the recovery of individuals with hemiplegia due to stroke. , Ekso Bionics ...
(Date:5/27/2016)... New York, NY (PRWEB) , ... May 27, ... ... caregivers to casual readers, this installment is bolstered by inspiring human-interest stories, courtesy ... trends and tech within the industry, from leading advocates, associations and industry leaders ...
(Date:5/27/2016)... ... ... Beleza Medspa has initiated a new program to assist active ... time that Coolsculpting is being used for for more than just cosmetic purposes. ... the prescribed body-fat standard, measured by the circumference-based tape method. The tape-test is ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... May 27, 2016 Hutchison ... company focused on the highly lucrative global oncology ... pipeline of potential first-in-class or best-in-class tyrosine kinase ... development with strategic partners. HCM,s profitable Chinese healthcare ... market. We expect progress of the mid-to-late-stage pipeline ...
(Date:5/27/2016)... 27, 2016 Amarantus BioScience Holdings, Inc. ... products for Regenerative Medicine, Neurology and Orphan Diseases, today announced that ... at two upcoming investor conferences: SeeThru Equity MicroCap ... New York City , NY When: ... Marcum MicroCap Conference   Where: Grand Hyatt Hotel, 109 ...
(Date:5/26/2016)... , May 26, 2016 According to ... Waste Management Market - U.S. Industry Analysis, Size, Share, Growth, ... market in the U.S. was valued at US$ 5.89 Bn ... of 3.4% from 2015 to 2023 to reach US$ 7.99 ... of current and emerging needle free drug delivery devices and ...
Breaking Medicine Technology: